CN1236059C - 一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 - Google Patents
一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 Download PDFInfo
- Publication number
- CN1236059C CN1236059C CNB031397700A CN03139770A CN1236059C CN 1236059 C CN1236059 C CN 1236059C CN B031397700 A CNB031397700 A CN B031397700A CN 03139770 A CN03139770 A CN 03139770A CN 1236059 C CN1236059 C CN 1236059C
- Authority
- CN
- China
- Prior art keywords
- insulin
- growth factor
- gene
- igf
- epinephelus coioide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 34
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 title claims description 91
- 241001417495 Serranidae Species 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000012634 fragment Substances 0.000 claims abstract description 19
- 239000002299 complementary DNA Substances 0.000 claims abstract description 14
- 239000000654 additive Substances 0.000 claims abstract description 6
- 210000004185 liver Anatomy 0.000 claims abstract description 6
- 230000000996 additive effect Effects 0.000 claims abstract description 5
- 241000357444 Epinephelus coioides Species 0.000 claims description 70
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims description 57
- 230000008859 change Effects 0.000 claims description 21
- 241000321428 Epinephelus guttatus Species 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 9
- 230000000968 intestinal effect Effects 0.000 claims description 9
- 230000003321 amplification Effects 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 230000008521 reorganization Effects 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000010839 reverse transcription Methods 0.000 claims description 5
- 230000035040 seed growth Effects 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 4
- 239000013599 cloning vector Substances 0.000 claims description 4
- 239000007952 growth promoter Substances 0.000 claims description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract description 4
- 241000251468 Actinopterygii Species 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000013535 sea water Substances 0.000 abstract description 2
- 102000013275 Somatomedins Human genes 0.000 abstract 3
- 230000006798 recombination Effects 0.000 abstract 2
- 238000005215 recombination Methods 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000003757 reverse transcription PCR Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 18
- 230000004087 circulation Effects 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 238000001502 gel electrophoresis Methods 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 7
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 7
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 108010076181 Proinsulin Proteins 0.000 description 4
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 3
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 3
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 102000003743 Relaxin Human genes 0.000 description 3
- 108090000103 Relaxin Proteins 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000007862 touchdown PCR Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 101100448444 Caenorhabditis elegans gsp-3 gene Proteins 0.000 description 2
- 241000357439 Epinephelus Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 102100023915 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 102220369446 c.1274G>A Human genes 0.000 description 2
- 102220369447 c.1352G>A Human genes 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 102220023257 rs387907546 Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000235789 Hyperoartia Species 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 241001600436 Plectroglyphidodon leucozonus Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000647 epithalamus Anatomy 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000652 hormesis Toxicity 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000000290 insulinogenic effect Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031397700A CN1236059C (zh) | 2003-07-10 | 2003-07-10 | 一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031397700A CN1236059C (zh) | 2003-07-10 | 2003-07-10 | 一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1487083A CN1487083A (zh) | 2004-04-07 |
CN1236059C true CN1236059C (zh) | 2006-01-11 |
Family
ID=34155090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031397700A Expired - Fee Related CN1236059C (zh) | 2003-07-10 | 2003-07-10 | 一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1236059C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102604897B (zh) * | 2012-03-28 | 2014-04-16 | 中国水产科学研究院淡水渔业研究中心 | 一种含有鲤IGF2b基因的慢病毒在提高鲤鱼产肉量上的应用 |
CN106508733A (zh) * | 2016-09-21 | 2017-03-22 | 华南农业大学 | 重组斜带石斑鱼IGF‑1和hCG联合促斜带石斑鱼卵巢成熟的应用 |
CN109694870A (zh) * | 2019-01-28 | 2019-04-30 | 河南师范大学 | 草鱼insulin基因及含有该基因的重组表达载体、重组菌及其应用 |
CN111018966B (zh) * | 2019-12-27 | 2022-07-29 | 河南师范大学 | Hemibarbus maculatus胰岛素样生长因子3、其蛋白、其抗体及应用 |
CN114621959B (zh) * | 2020-12-08 | 2023-05-26 | 中国科学院海洋研究所 | 一种编码牙鲆igf2可溶性蛋白的基因及蛋白重组表达方法与应用 |
-
2003
- 2003-07-10 CN CNB031397700A patent/CN1236059C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1487083A (zh) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101063104A (zh) | 一种生产5-氨基乙酰丙酸的工程菌及其构建方法 | |
Sekar et al. | Cloning and characterization of Pangasianodon hypophthalmus growth hormone gene and its heterologous expression | |
CN1793375A (zh) | 重组人神经生长因子的酵母表达系统及制备重组人神经生长因子的方法 | |
CN1236059C (zh) | 一种石斑鱼胰岛素样生长因子ⅱ基因、含有该基因的载体、重组株及其应用 | |
CN1654656A (zh) | 中国明对虾Crustin基因和编码蛋白及其克隆方法 | |
CN1873006A (zh) | 一种重组人胰岛素原的生产方法 | |
CN109997970B (zh) | 一类酶活和耐热性提高的酸性木聚糖酶突变体及其编码基因和应用 | |
CN100344758C (zh) | 中国对虾含单一乳清酸性蛋白结构域的抗菌肽基因及其所编码的抗菌肽与应用 | |
CN1231585C (zh) | 重组鸭白介素2蛋白的制备方法及其用途 | |
CN1238378C (zh) | 一种抗菌肽及其编码序列和用途 | |
CN1958797A (zh) | 南极假丝酵母脂肪酶的核苷酸序列 | |
CN1181199C (zh) | 地衣形芽孢杆菌l-25角蛋白酶及编码该角蛋白酶的dna | |
CN1831109A (zh) | 一种编码高温植酸酶基因的重组菌和该基因及其合成、克隆和表达 | |
CN100336906C (zh) | 脂肪酶基因序列及其在酵母中的应用 | |
CN1803846A (zh) | p53蛋白的表位(SQAMDDLMLS)与丝状噬菌体基因8蛋白的杂合蛋白及其应用 | |
CN1029989C (zh) | 在链霉菌中制备异种蛋白的方法 | |
CN101050448A (zh) | 一种促进动物生长的口服重组dna疫苗及应用 | |
CN1818068A (zh) | 重组人白细胞介素-2(125ser)表达载体的构建 | |
CN1740320A (zh) | 中国明对虾抗脂多糖因子基因及其克隆方法 | |
CN1844390A (zh) | 鸭B淋巴细胞刺激因子cDNA及其克隆方法和重组应用 | |
CN1273599C (zh) | 中国青岛文昌鱼硫氧还蛋白过氧化物酶基因及其应用 | |
CN1157477C (zh) | 含有大鳞大马哈鱼生长因子的大肠杆菌 | |
CN1482253A (zh) | 南方鲇生长激素基因 | |
CN1763092A (zh) | 一种抗菌肽及其编码序列和用途 | |
CN110592054B (zh) | 海马孵化酶基因及其编码蛋白和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Bada Forage Co., Ltd., Nantong Assignor: Sun Yat-sen University Contract fulfillment period: 2007.8.5 to 2012.12.31 Contract record no.: 2009320000483 Denomination of invention: Grouper insulin-like growth factor II gene, carrier and recombinant strain containing the gene and application thereof Granted publication date: 20060111 License type: Exclusive license Record date: 2009.3.23 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.8.5 TO 2012.12.31; CHANGE OF CONTRACT Name of requester: NANTONG BADA FEEDINGS CO., LTD. Effective date: 20090323 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060111 Termination date: 20170710 |